<SEC-DOCUMENT>0001140361-22-022594-index.html : 20220610 <SEC-HEADER>0001140361-22-022594.hdr.sgml : 20220610 <ACCEPTANCE-DATETIME>20220610161526 ACCESSION NUMBER: 0001140361-22-022594 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20220610 DATE AS OF CHANGE: 20220610 GROUP MEMBERS: DAVID C. OTT GROUP MEMBERS: O. ANDREAS HALVORSEN GROUP MEMBERS: ROSE S. SHABET GROUP MEMBERS: VIKING GLOBAL EQUITIES II LP GROUP MEMBERS: VIKING GLOBAL EQUITIES MASTER LTD. GROUP MEMBERS: VIKING GLOBAL PERFORMANCE LLC GROUP MEMBERS: VIKING LONG FUND GP LLC GROUP MEMBERS: VIKING LONG FUND MASTER LTD. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Celldex Therapeutics, Inc. CENTRAL INDEX KEY: 0000744218 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133191702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-37761 FILM NUMBER: 221009060 BUSINESS ADDRESS: STREET 1: 53 FRONTAGE ROAD STREET 2: SUITE 220 CITY: HAMPTON STATE: NJ ZIP: 08827 BUSINESS PHONE: 908-200-7500 MAIL ADDRESS: STREET 1: 53 FRONTAGE ROAD STREET 2: SUITE 220 CITY: HAMPTON STATE: NJ ZIP: 08827 FORMER COMPANY: FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19980828 FORMER COMPANY: FORMER CONFORMED NAME: T CELL SCIENCES INC DATE OF NAME CHANGE: 19920703 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: VIKING GLOBAL INVESTORS LP CENTRAL INDEX KEY: 0001103804 IRS NUMBER: 134055118 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 55 RAILROAD AVENUE CITY: GREENWICH STATE: CT ZIP: 06830 BUSINESS PHONE: 212-672-7050 MAIL ADDRESS: STREET 1: 55 RAILROAD AVENUE CITY: GREENWICH STATE: CT ZIP: 06830 </SEC-HEADER> <DOCUMENT> <TYPE>SC 13G <SEQUENCE>1 <FILENAME>brhc10038648_sc13g.htm <DESCRIPTION>SC 13G <TEXT> Document 1 - file: brhc10038648_sc13g.htm
</DOCUMENT> </SEC-DOCUMENT>